Swaranjit Chani
Internal Medicine · Horse Cave, KYNPI 1619953700
Payments from drug & device makers
Across 246 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$792
- Bayer$308
- Lilly USA, LLC$278
- AbbVie$275
- Amgen$235
- Amarin Pharma, Inc.$228
- plus $2K from 17 others
What the payments were for
- Food & beverage$3,697100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 60 | $792 |
| Bayer | 18 | $308 |
| Lilly USA, LLC | 19 | $278 |
| AbbVie(2 entities) | 17 | $275 |
| Amgen | 13 | $235 |
| Amarin Pharma, Inc. | 16 | $228 |
| Novartis | 13 | $227 |
| GSK | 15 | $210 |
| Merck | 15 | $175 |
| Pfizer | 12 | $173 |
| Dexcom, Inc. | 9 | $140 |
| AstraZeneca | 9 | $126 |
| Sanofi-aventis U.S. LLC | 5 | $100 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $87 |
| Johnson & Johnson | 6 | $83 |
| Corcept Therapeutics | 4 | $81 |
| Lundbeck LLC | 2 | $47 |
| Astellas Pharma US Inc | 3 | $46 |
| Mylan Specialty L.p. | 2 | $26 |
| Boehringer Ingelheim | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Exact Sciences | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $13 |
How this compares
$3,697 in reported general payments places this provider in the 85th percentile of 1,284 internal medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 101 | $119,157 |
| JardianceEmpagliflozin | 158 | $96,387 |
| EliquisApixaban | 170 | $85,955 |
| NamzaricMemantine Hcl/Donepezil Hcl | 247 | $74,344 |
| MounjaroTirzepatide | 35 | $36,607 |
| Tresiba Flextouch U-100Insulin Degludec | 41 | $31,596 |
| FarxigaDapagliflozin Propanediol | 44 | $28,160 |
| JanuviaSitagliptin Phosphate | 34 | $27,690 |
| TrulicityDulaglutide | 21 | $23,633 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $15,804 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $15,624 |
| Xtampza ErOxycodone Myristate | 12 | $13,789 |
| LinzessLinaclotide | 20 | $13,527 |
| VascepaIcosapent Ethyl | 30 | $12,606 |
| MyrbetriqMirabegron | 44 | $12,452 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $792 | $119,157101 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $17 | $104,625174 claims |
| AbbVieNamzaric, Linzess | $275 | $87,871267 claims |
| PfizerEliquis | $173 | $85,955170 claims |
| Lilly USA, LLCMounjaro, Trulicity | $278 | $60,24056 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Lokelma | $126 | $50,36286 claims |
| MerckJanuvia, Janumet | $175 | $39,47369 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta | $210 | $27,51151 claims |
| Astellas Pharma US IncMyrbetriq | $46 | $12,45244 claims |
| Johnson & JohnsonXarelto | $83 | $10,39032 claims |
| NovartisEntresto | $227 | $7,29111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Horse Cave
- Mark AdamsLondon$15.4M
- Matthew WenkerErlanger$12.8M
- Jason ChesneyLouisville$6.3M
- Neil FarrisLexington$3M
- David JohnsonOwensboro$787K
- Hollis ClarkMurray$780K
- Fares KhaterWhitesburg$412K
- Christopher PhillipsPaducah$315K
- Cynthia Bowman-StroudPaducah$234K
- Bernard BuchananOwensboro$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.